Cocrystal Pharma Inc (COCP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 6,564 | 0 | 0 | 0 | 78 |
| Gross Profit | 6,564 | N/A | N/A | N/A | 78 |
| Operating Expenses | 54,970 | 62,924 | 8,262 | 105,819 | 54,026 |
| Operating Income | -48,406 | -62,924 | -8,262 | -105,819 | -53,948 |
| Interest Expense | 19 | 58 | 7 | 0 | 0 |
| Other Income | 256 | 352 | 776 | 1,551 | -11,422 |
| Pre-tax Income | -48,169 | -62,630 | -7,493 | -104,268 | -65,370 |
| Income Tax | N/A | -13,582 | -6,880 | -29,394 | -15,248 |
| Net Income Continuous | -48,169 | -49,048 | -613 | -74,874 | -50,122 |
| Net Income | $-48,169 | $-49,048 | $-613 | $-74,874 | $-50,122 |
| EPS Basic Total Ops | -18.13 | -21.01 | -0.36 | -38.18 | -28.81 |
| EPS Basic Continuous Ops | -18.15 | -21.02 | -0.31 | -38.22 | -28.64 |
| EPS Diluted Total Ops | -18.13 | -21.01 | -0.36 | -39.62 | -28.81 |
| EPS Diluted Continuous Ops | -18.15 | -21.02 | -0.31 | -38.20 | -28.64 |
| EPS Diluted Before Non-Recurring Items | -0.72 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-2,049 | $-62,874 | $-8,161 | $-105,618 | $-53,756 |